Syntheses of biotinylated α-galactosylceramides and their effects on the immune system and CD1 molecules

被引:49
作者
Sakai, T
Naidenko, OV
Iijima, H
Kronenberg, M
Koezuka, Y
机构
[1] Kirin Brewery Co Ltd, Pharmaceut Res Lab, Takasaki, Gumma 3701295, Japan
[2] La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA
关键词
D O I
10.1021/jm990054n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A representative alpha-galactosylceramide (alpha-GalCer), KRN7000, has strong immunostimulatory and antitumor activity. Recent studies demonstrated that KRN7000-pulsed antigen-presenting cells (APC) can activate natural killer T (NKT) cells, a novel T-cell lineage, and CD1d molecules on APC play an important role in the activation of NKT cells. However, it remains unclear whether alpha-GalCers actually bind to CD1d molecules. To address this question, we synthesized three kinds of biotinylated alpha-GalCer and a biotinylated beta-GalCer and found that the biotinylated alpha-GalCers significantly stimulate the proliferation of murine spleen cells, but the biotinylated beta-GalCer does not and that all biotinylated compounds bind to CD1d molecules.
引用
收藏
页码:1836 / 1841
页数:6
相关论文
共 26 条
[11]   Molecular interaction of CD1b with lipoglycan antigens [J].
Ernst, WA ;
Maher, J ;
Cho, SG ;
Niazi, KR ;
Chatterjee, D ;
Moody, DB ;
Besra, GS ;
Watanabe, Y ;
Jensen, PE ;
Porcelli, SA ;
Kronenberg, M ;
Modlin, RL .
IMMUNITY, 1998, 8 (03) :331-340
[12]   Structure-activity relationship and conformational analysis of monoglycosylceramides on the syngeneic mixed leukocyte reaction [J].
Iijima, H ;
Kimura, K ;
Sakai, T ;
Uchimura, A ;
Shimizu, T ;
Ueno, H ;
Natori, T ;
Koezuka, Y .
BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (10) :1905-1910
[13]   The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens [J].
Jackman, RM ;
Stenger, S ;
Lee, A ;
Moody, DB ;
Rogers, RA ;
Niazi, KR ;
Sugita, M ;
Modlin, RL ;
Peters, PJ ;
Porcelli, SA .
IMMUNITY, 1998, 8 (03) :341-351
[14]   CD1d-restricted and TCR-mediated activation of V(alpha)14 NKT cells by glycosylceramides [J].
Kawano, T ;
Cui, JQ ;
Koezuka, Y ;
Toura, I ;
Kaneko, Y ;
Motoki, K ;
Ueno, H ;
Nakagawa, R ;
Sato, H ;
Kondo, E ;
Koseki, H ;
Taniguchi, M .
SCIENCE, 1997, 278 (5343) :1626-1629
[15]   Enhancing effects of alpha,beta-monoglycosylceramides on natural killer cell activity [J].
Kobayashi, E ;
Motoki, K ;
Yamaguchi, Y ;
Uchida, T ;
Fukushima, H ;
Koezuka, Y .
BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (04) :615-619
[16]   STRUCTURE-ACTIVITY RELATIONSHIP OF ALPHA-GALACTOSYLCERAMIDES AGAINST B16-BEARING MICE [J].
MORITA, M ;
MOTOKI, K ;
AKIMOTO, K ;
NATORI, T ;
SAKAI, T ;
SAWA, E ;
YAMAJI, K ;
KOEZUKA, Y ;
KOBAYASHI, E ;
FUKUSHIMA, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (12) :2176-2187
[17]   SYNTHESES OF ALPHA-MONOGLYCOSYLCERAMIDES, BETA-MONOGLYCOSYLCERAMIDES AND 4 DIASTEREOMERS OF AN ALPHA-GALACTOSYLCERAMIDE [J].
MORITA, M ;
NATORI, T ;
AKIMOTO, K ;
OSAWA, T ;
FUKUSHIMA, H ;
KOEZUKA, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (07) :699-704
[18]  
Nakagawa R, 1998, CANCER RES, V58, P1202
[19]   Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner [J].
Nieda, M ;
Nicol, A ;
Koezuka, Y ;
Kikuchi, A ;
Takahashi, T ;
Nakamura, H ;
Furukawa, H ;
Yabe, T ;
Ishikawa, Y ;
Tadokoro, K ;
Juji, T .
HUMAN IMMUNOLOGY, 1999, 60 (01) :10-19
[20]  
PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X